Skip to content
Clinical Trials – home
ItalyBack to Italy

Clinical trials in Taranto

9 clinical trials in Taranto, Italy. Every trial is listed in the EU Clinical Trials Register and updated daily.

ItalyOur site in ItalyStudi-Clinici.it(opens in a new tab)
Taranto at a glance
9
clinical trials
  • Research sites0
Type of trial
Recruitment status
Quick filters

9 trials in Taranto

Open in trial search
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Depemokimab
  • Sponsor:Glaxosmithkline Research & Development Limited
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Sponsor:Generate Biomedicines Inc.
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Budesonide
  • Sponsor:F. Hoffmann-La Roche AG
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years · 65+ years
  • Substances:Cyclophosphamide
  • Sponsor:The University Of Birmingham
Countries:ItalyItaly
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Universita' Degli Studi Di Torino
Countries:ItalyItaly
  • Participants:0–17 years · 18–64 years
  • Substances:Busulfan
  • Sponsor:GPOH gGmbH
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Cytarabine
  • Sponsor:GPOH gGmbH
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Blinatumomab
  • Sponsor:Universitaetsklinikum Schleswig-Holstein AöR
Countries:ItalyItaly
  • Participants:0–17 years
  • Substances:Alemtuzumab
  • Sponsor:St. Anna Childrens Cancer Research Institute GmbH

Other cities in Italy

The busiest research cities in the country

All 232 cities in Italy

Clinical research in Taranto

What the registry says about research in the country

01 Lung Cancer Research

Innovative clinical trials focusing on non-small cell lung cancer treatment, specifically evaluating maintenance therapy approaches for unresectable stage III cases. Research explores the effectiveness of immunotherapy following chemo-radiotherapy treatments.

  • Advanced Stage Treatment
  • Maintenance Therapy
  • Survival Outcomes

These studies aim to improve long-term survival rates for patients with locally advanced disease.

02 Pediatric Leukemia Studies

Comprehensive research program investigating various forms of leukemia, including acute lymphoblastic leukemia and myeloid leukemia in children. Special focus on innovative treatment protocols for specific patient groups, including children with Down Syndrome.

  • Targeted Therapies
  • Immunotherapy Approaches
  • Risk-Adapted Treatment

Multiple trial arms evaluate different therapeutic strategies to enhance survival rates and reduce treatment-related complications.

03 Rare Cancers Research

Groundbreaking studies on Rhabdomyosarcoma and Langerhans Cell Histiocytosis, developing comprehensive treatment protocols for both children and adults. Research encompasses various disease stages and risk levels.

  • Novel Drug Combinations
  • Radiotherapy Optimization
  • Treatment Duration Studies

These trials aim to establish more effective treatment strategies for rare cancer types, particularly focusing on pediatric cases.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.